A concise review of mushrooms antiviral and immunomodulatory properties that may combat against COVID-19.

Autor:	Arunachalam K; Key Laboratory of Economic Plants and Biotechnology, The Yunnan Key Laboratory for Wild Plant Resources, Kunming Institute of Botany, Chinese Academy of Sciences, Kunming 650201, China.; University of Chinese Academy of Sciences, Beijing 100049, China., Sasidharan SP; Department of Botany, NSS College, Nemmara, Palakkad, Kerala, India., Yang X; Key Laboratory of Economic Plants and Biotechnology, The Yunnan Key Laboratory for Wild Plant Resources, Kunming Institute of Botany, Chinese Academy of Sciences, Kunming 650201, China.; University of Chinese Academy of Sciences, Beijing 100049, China.
Jazyk:	angličtina
Zdroj:	Food chemistry advances [Food Chem Adv] 2022 Oct; Vol. 1, pp. 100023. Date of Electronic Publication: 2022 Mar 02.
DOI:	10.1016/j.focha.2022.100023
Abstrakt:	The World Health Organization (WHO) declared COVID-19 as a pandemic on March 11, 2020, because of its widespread transmission and infection rates. The unique severe disease was found in Wuhan, China, since December 2019, and swiftly spread throughout the world. Natural chemicals derived from herbal medicines and medicinal mushrooms provide a significant resource for the development of novel antiviral drugs. Many natural drugs have been proven to have antiviral properties against a variety of virus strains, such as the coronavirus and the herpes simplex virus (HSV).. In this research, successful dietary treatments for different COVID illnesses were compared to potential of mushroom products in its therapy. In Google Scholar, Science Direct, PubMed, and Scopus, search keywords like COVID, COVID-19, SARS, MERS, mushrooms, and their compounds were utilized. In this review of the literature we foucsed popular mushrooms such as Agaricus subrufescens Peck , Agaricus blazei Murill, Cordyceps sinensis (Berk.) Sacc. , Ganoderma lucidum (Curtis.) P. Karst. , Grifola frondosa (Dicks.) Gray , Hericium erinaceus (Bull.) Pers. , Inonotus obliquus (Arch. Ex Pers.) Pilát. , Lentinula edodes (Berk.) Pegler , Pleurotus ostreatus (Jacq.) P. Kumm. , Poria cocos F.A. Wolf, and Trametes versicolor (L.) Lloyd.,. Changed forms of β-Glucan seem to have a good impact on viral replication suppression and might be used in future studies. However, the results seems terpenoids, lectins, glycoproteins, lentinan, galactomannan, and polysaccharides from mushrooms are promising prophylactic or therapeutic agents against COVID-19. Competing Interests: The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. (© 2022 The Author(s).)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu